Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPTc Regimens in Senegalese Children
NCT00132548Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of sulfadoxine + pyrimethamine, artesunate and amodiaquine in malaria (4 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Prevalence of markers of drug resistance to pyrimethamine and sulfonamides. Started Jun 2004; status: completed.
02
Drugs
sulfadoxine + pyrimethamineartesunateamodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00132548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132548.